Exploring Therapeutic Options for Acromegaly

Tomorrow morning, our Stinson Brand Innovation market research team will be attending a symposium entitled, "Exploring Therapeutic Options for Acromegaly."

The Program Director is Steven G. Waguespack, MD of the University of Texas MD Anderson Cancer Center.

Here is an overview of the program agenda:
 

"Initial Care of the Patient with Acromegaly: Medical Management, Surgical Management, or Both?"
Roberto Salvatori, MD, Johns Hopkins Univ
 

"The Use of Somatostatin Analogs in Clinical Practice," Marcello Bronstein, MD, Univ of Sao
Paulo (Brazil)
 

"The Patient with Resistant Acromegaly: Current & Future Options for Treatment," Ashley Grossman, MD, St Bartholomew's Hosp (London)

Learning Objectives:
Upon completion of this educational activity, participants should be better able to:

• Explain the risks and benefits of surgical, medical, and radiotherapeutic treatment options for acromegaly
• Discuss the role of medical therapeutic options as monotherapy or in combination with other medical, surgical and radiotherapeutic interventions
• Discuss current and future treatment options for the patient with acromegaly refractory to initial medical and/or surgical therapies